Abstract
The 1-arylimidazole-2-thiones, (HmimAr) [Ar = 3,4,5-C6H2(OMe)3, 2,4-C6H3(NO2)(OMe), 2,4,6-C6H2Cl3 and 3,5-C6H3(CF3)2], which feature electronically diverse substituents, may be obtained via acid-catalyzed ring closure of the corresponding N,N′-aryldiethoxyethylthiourea derivatives, ArN(H)C(S)N(H)CH2CH(OEt)2, (H2detuAr), which in turn are obtained via treatment of aminoacetaldehyde diethyl acetal, H2NCH2CH(OEt)2, with the respective arylisothiocyanates (ArNCS). The molecular structures of all of the above N,N′-aryldiethoxyethylthioureas and 1-arylimidazole-2-thiones have been determined by X-ray diffraction, thereby demonstrating that the substituents have a profound effect on the crystal structures. For example, each of the N,N′-aryldiethoxyethylthiourea derivatives adopts a different hydrogen bonding pattern. Specifically, the hydrogen-bonding network in (i) H2detuArCl3 consists of chains of 9-membered rings, with an [ (9)] motif, that feature one N–H ⋯ O and one N–H ⋯ S interaction, (ii) H2detuArOMe,NO2 consists of chains of 6-membered rings, with an [ (6)] motif, that feature two head-to-tail N–H ⋯ S interactions, (iii) H2detuAr(CF3)2 consists of a dimer that features two pairs of N–H ⋯ O interactions, of which each pair is a component of an 8-membered ring with an [ (8)] motif, and (iv) H2detuAr(OMe)3 consists of a chain of head-to-head dimeric rings with a basic [ (16)] motif, a notable feature of which is that sulfur does not play a role as a hydrogen bond acceptor. Each of the 1-arylimidazole-2-thiones exists as a “head-to-head” hydrogen-bonded dimer in the solid state, with an [ (8)] motif. However, while the hydrogen-bonded motifs for HmimArCl3 and HmimAr(OMe)3 are planar, those for HmimAr(CF3)2 and HmimArOMe,NO2 are extremely puckered, with fold angles of 24.2° (mean value) and 45.7°, respectively.
Introduction
1-R-imidazole-2-thiones (HmimR),1,2,3,4,5 which are often referred to in terms of their tautomeric 2-mercapto-1-R-imidazole form (Figure 1),6 despite the fact that the thione form is dominant,3 represent an important class of molecules that has found widespread applications in fields ranging from medicinal to coordination chemistry.
Figure 1.

Tautomers of HmimR.
For example, with respect to medicinal applications, the parent methyl derivative, methimazole (also known as tapazole), is a widely used antithyroid drug,7,8 and a variety of other derivatives are potent multisubstrate inhibitors of β-hydroxylase,2c,3d,9 octopamine agonists3b and CCR2 antagonists.2b,10 In addition, imidazole-2-thiones are used as reagents for the synthesis of compounds that are employed in imaging by positron emission tomography.11 With respect to applications in coordination chemistry, HmimR derivatives have been used as ligands (in both protonated and deprotonated forms)12 for a variety of metals. For example, in terms of mercury chemistry, coordination of HmimR has been shown to promote protolytic cleavage of Hg–C bonds.13 1-R-imidazole-2-thiones have also been employed to construct a family of bis(mercaptoimidazolyl)hydroborato and tris(mercaptoimidazolyl)hydroborato ligands, [BmR] and [TmR], that respectively provide [S2] and [S3] donor arrays, of which the latter have been used to provide synthetic analogues of zinc enzymes (e.g. 5‐aminolevulinate dehydratase and the ADA DNA repair protein)14,15 and organomercurial lyase (Mer B).13a Furthermore, [TmR] ligands have also been used to afford access to metallaboratranes that feature novel retrodative M→B bonds.16 In view of the diverse applications of this class of molecules, it is surprising that only one structurally characterized 1-arylimidazole-2-thione derivative is listed in the Cambridge Structural Database,17 namely HmimTol.18,19 Therefore, we report here the synthesis and structural characterization of a variety of HmimAr compounds that contain electronically diverse substituents (Figure 2). In addition, we also describe the structures of the corresponding N,N′-aryldiethoxyethylthiourea intermediates. Compounds of this class have not been previously structurally characterized, despite the fact that N,N′-disubstituted thioureas have varied applications.20,21 Some examples of these applications include their use (i) as antibacterial,22,23,24 antifungal,24,25 antiviral,26,27,28 anti-HIV,28 antimalarial,23 antituberculous,28,29 antihistamine,30 and anticancer27 agents, (ii) in organocatalysis,31,32,33 and (iii) in crystal engineering.34,35
Figure 2.

HmimAr ligands.
Results and Discussion
Synthesis of 1-arylimidazole-2-thiones, HmimAr
The 1-arylimidazole-2-thiones, HmimAr [Ar = 3,4,5-C6H2(OMe)3, 2,4-C6H3(NO2)(OMe), 2,4,6-C6H2Cl3 and 3,5-C6H3(CF3)2], may be obtained via the two-step process illustrated in Scheme 1.3,36 Specifically, treatment of aminoacetaldehyde diethyl acetal, H2NCH2CH(OEt)2, with the respective arylisothiocyanate (ArNCS) gives the N,N′-aryldiethoxyethylthiourea derivative, ArN(H)C(S)N(H)CH2CH(OEt)2, (H2detuAr), which is converted to the 1-arylimidazole-2-thione by acid-catalyzed ring closure. In each case, both the 1-arylimidazole-2-thione, HmimAr, and the intermediate thiourea, H2detuAr, can be isolated in good yields by crystallization.
Scheme 1.

Synthesis of H2detuAr and HmimAr.
Molecular structures of N,N′-aryldiethoxyethylthioureas, H2detuAr
Despite the fact that thioureas have considerable synthetic utility3,31-33 and applications in crystal engineering,34,35 there are no structurally characterized examples of N,N′-aryldiethoxyethylthioureas listed in the Cambridge Structural Database.17 The structures of N,N′-aryldiethoxyethylthioureas are also of interest because the presence of multiple potential hydrogen bond acceptor groups is expected to influence the hydrogen bonding patterns in their extended structures. In this regard, X-ray diffraction studies reveal that the molecular structures of H2detuAr are highly dependent on the nature of the aryl substituent, as illustrated in Figure 3 and Figure 4.
Figure 3.

Molecular structures of H2detuArCl3 (left) and H2detuAr(OMe)3 (right).
Figure 4.

Molecular structures of H2detuAr(CF3)2 (top) and H2detuArOMe,NO2 (bottom).
With respect to the orientation of the thiourea substituents, previous studies have demonstrated that N,N′-disubstituted thioureas may exist in solution in different rotameric forms, which have been classified as trans-trans, trans-cis and cis-cis, based on their H–N–C–S dihedral angles, as illustrated in Figure 5.37 Of these, the trans-trans and trans-cis rotamers typically have comparable energies, while the cis-cis has a significantly higher energy, such that the vast majority of N,N′-disubstituted thioureas exist in the solid state as either trans-trans or trans-cis rotamers;34,38 these rotamers are also respectively referred to as syn and anti with respect to the relative positions of the N–H groups.39 On this basis, H2detuArCl3 and H2detuAr(OMe)3 are classified as adopting a trans-cis (anti) disposition of N–H groups (Figure 3), while H2detuAr(CF3)2 and H2detuArOMe,NO2 adopt a trans-trans (syn) disposition (Figure 4).
Figure 5.

Rotamers of thioureas.
The C=S bond lengths in the thiourea compounds reported here are in the range 1.67 – 1.70 Å (Table 1) and are comparable to those of other thiourea derivatives (1.68 Å).40 Furthermore, the distances pertaining to the various N ⋯ S and N ⋯ O hydrogen bonding interactions (Table 1) are also comparable to literature values (3.44 Å40,41 and 2.95 Å,42 respectively).
Table 1.
Selected metrical data for H2detuAr derivatives [R = CH2CH(OEt)].
| d(N ⋯ O)/Å | d(N⋯O)/Å | d(N ⋯ S)/Å | d(NH ⋯ O)/Å | d(NH ⋯ O)/Å | d(NH ⋯ S)/Å | d(C=S)/Å | N1–C–N2/° | |
|---|---|---|---|---|---|---|---|---|
| H2detuArCl3 | 3.012(2) (ArN … OEt) |
3.246(2) (NR) | 2.24(2) (ArN … OEt) |
2.49(2) (NR) | 1.691(2) | 116.66(19) | ||
| H2detuAr(OMe)3 | 3.015(2), 2.976(2) (RN … OMe) |
2.900(2), 2.882(2) (ArN … OEt) |
2.32(2), 2.21(2) (RN … OMe) |
2.01(2), 2.060(19) (ArN … OEt) |
1.6938(17), 1.6904(17) |
116.75(15), 123.40(13) |
||
| H2detuAr(CF3)2 | 3.141(2), 3.002(2) (RN … OEt) |
2.955(2), 3.070(2) (ArN … OEt) |
2.21(2), 2.31(2) (RN … OEt) |
2.29(2), 2.10(2) (ArN … OEt) |
1.6693(19) 1.677(2) |
112.43(16), 113.06(17) |
||
| H2detuAr(CF3)2 | 3.070(2), 3.142(2) (RN … OEt) |
3.002(2), 2.956(2) (ArN … OEt) |
2.29(2), 2.32(2) (RN … OEt) |
2.20(2), 2.10(2) (ArN … OEt) |
1.6697(18), 1.6766(19) |
112.43(15), 113.09(16) |
||
| H2detuArOMe,NO2 | 3.348(3) (NR) 3.541(3) (NAr) |
2.52(3) (NR), 2.80(2) (NAr) |
1.684(3) | 113.4(3) |
In addition to the syn/anti differences in the molecular structures, the compounds also exhibit significant differences with respect to their hydrogen bonding interactions, as illustrated in Figures 7 – 10.43 For reference, trans-trans (syn) rotamers are typically observed to form linear44 chains in which both N–H groups interact with a single thiocarbonyl sulfur in a bifurcated45 manner, whereas trans-cis (anti) rotamers typically form dimers (Figure 6);34 in terms of graph-set notation,46 these networks are classified as C(4)[ (6)] and [ (8)], respectively. It is, therefore, evident from examination of Figures 7 – 10 that the aryldiethoxyethylthioureas reported here comprise much more varied hydrogen bonding networks than those presented in Figure 6. Specifically, the N–H groups of the thiourea moiety may interact with different combinations of hydrogen bond acceptors, such that each compound exhibits a distinctive network, as summarized in Table 1 and Table 2.
Figure 7.

Hydrogen bonding network for H2detuAr(CF3)2.
Figure 10.

Hydrogen bonding network for H2detuAr(OMe)3.
Figure 6.

Typical hydrogen bonding networks in thioureas.
Table 2.
Hydrogen bonding networks for H2detuAr derivatives.
| Unitary Network | Binary Network | ||
|---|---|---|---|
| H2detuArCl3 | C(4)C(7) |
|
|
| H2detuAr(OMe)3 | DDDD |
|
|
| H2detuAr(CF3)2 | DDDD |
|
|
| H2detuArOMe,NO2 | C(4)C(4) |
|
For example, rather than adopt the chain-like structure that is typical for trans-trans (syn) rotamers (Figure 6), H2detuAr(CF3)2 exists as a discrete dimeric species with approximate C2 symmetry (Figure 7). Thus, rather than hydrogen bond with the sulfur, the N–H groups of each thiourea moiety form intermolecular N–H ⋯ O hydrogen bonds with two oxygen atoms of a single diethoxyethyl group, CH2CH(OEt)2, thereby resulting in an 8-membered ring with an [ (8)] motif.
In contrast, H2detuArOMe,NO2, which also possesses a syn disposition of N–H groups, does not exhibit any intermolecular N–H ⋯ O hydrogen bonding interactions with either the CH2CH(OEt)2, OMe or NO2 groups.47 Instead, the pair of N–H groups exhibit intermolecular “head-to-tail” hydrogen bonding interactions with a single sulfur atom, thereby resulting in a chain of a 6-membered rings, each one of which possesses an [ (6)] motif (Figure 8). The overall hydrogen bonding network is described by the binary graph set (8)[ (6)] and is well-precedented for thioureas that possess a syn disposition of N–H groups (Figure 6).48
Figure 8.

Hydrogen bonding network for H2detuArOMe,NO2.
H2detuArCl3 exists as a trans-cis (anti) rotamer, but rather than form a simple dimer by the centrosymmetric interaction of two thiourea [S/NH] pairs (Figure 6), H2detuArCl3 forms a structure that results from an interaction between a pair of [S/NH] and [O/NH] moieties, thereby resulting in a 9-membered ring with an [ (9)] motif that features one N–H ⋯ O and one N–H ⋯ S interaction. In addition to the oxygen atom of the ethoxy groups allowing for an unusual type of ring structure, it also provides a means to create an extended chain structure by virtue of there being an additional hydrogen bond acceptor present. Thus, whereas the dimeric structures observed for other trans-cis (anti) rotamers utilize only one N–H bond per urea (Figure 6), both N–H bonds are utilized for H2detuArCl3, such that the hydrogen bonding network is described by the binary graph set (11)[ (9)].
The extended structure of H2detuAr(OMe)3 is unique because, in contrast to the other derivatives that form chains (H2detuArCl3 and H2detuArOMe,NO2), it does not utilize sulfur as a hydrogen bond acceptor.49 Rather, each thiourea moiety of H2detuAr(OMe)3 exhibits two intermolecular N–H ⋯ O hydrogen bonding interactions, one with an oxygen atom of the diethoxyethyl group and one with an oxygen atom of a methoxy group (Figure 10). The overall result may be described as a polymeric chain of “head-to-head” H2detuAr(OMe)3 dimeric units, each of which is composed of a 16-membered ring with a basic [ (16)] motif.
Molecular structures of 1-arylimidazole-2-thiones
The molecular structures of HmimAr [Ar = 3,4,5-C6H2(OMe)3, 2,4-C6H3(NO2)(OMe), 2,4,6-C6H2Cl3 and 3,5-C6H3(CF3)2] have been determined by X-ray diffraction, as illustrated in Figures 11 – 14.
Figure 11.

Molecular structure of hydrogen bonded HmimArCl3.
Figure 14.

Molecular structure of hydrogen bonded HmimArOMe,NO2.
Each of the compounds exists as a “head-to-head” hydrogen bonded dimer in the solid state, with an [ (8)] motif, which is common for this class of compound.50 However, while the hydrogen-bonded dimers of HmimArCl3 and HmimAr(OMe)3 are planar, those of HmimAr(CF3)2 and HmimArOMe,NO2 are extremely puckered, as illustrated for the latter in Figure 15.
Figure 15.

View of the non-planar hydrogen bonded [ (8)] motif in HmimArOMe,NO2.
For example, the fold angle about the S ⋯ S vector for HmimArOMe,NO2 is 45.7° (Table 3). Nevertheless, despite the varying deviations from planarity among the HmimAr compounds reported here, their N–H ⋯ S hydrogen bond distances do not vary dramatically (Table 3). Although a possible explanation for the large deviation for HmimArOMe,NO2 could be attributed to the presence of an ortho NO2 substituent, it should be recognized that the methyl derivative, HmimMe, also exhibits a highly bent [ (8)] ring, with a fold angle of 58.2°,51 which indicates that steric factors are not likely responsible. Thus, it is evident that the nonplanarity of the 8-membered hydrogen bond rings in this system is dictated by packing forces rather than any electronic effect that influences the N–H ⋯ S hydrogen bonding interactions.
Table 3.
Selected metrical data for HmimAr derivatives.
| d(C=S)/Å | N1–C–N2/° | d(N ⋯ S)/Å | d(H ⋯ S)Å | N–H ⋯ S/° | Fold Angle/°a | Ar twist/°b | |
|---|---|---|---|---|---|---|---|
|
| |||||||
| HmimArCl3 | 1.6881(12) | 104.96(10) | 3.2511(11) | 2.413(19) | 174.1(17) | 0.00 | 89.13 |
|
| |||||||
| HmimAr(OMe)3 | 1.6896(17) | 104.94(14) | 3.2662(15) | 2.36(2) | 171.2(17) | 0.00 | 56.77 |
|
| |||||||
| HmimAr(CF3)2 | 1.692(2), 1.692(2) | 105.23(18), 104.87(18) | 3.278(2), 3.284(2) | 2.50(1), 2.45(3) | 178(3), 168(3) | 22.87 | 43.65, 45.94 |
| 1.692(2), 1.689(2) | 104.85(19), 104.72(18) | 3.291(2), 3.260(2) | 2.46(3), 2.43(3) | 178(3), 160(3) | 23.47 | 42.28, 49.09 | |
| 1.692(2), 1.690(2) | 105.19(19), 105.5(2) | 3.370(2), 3.206(2) | 2.54(4), 2.39(4) | 167(4), 170(3) | 26.19 | 44.52, 58.72 | |
|
| |||||||
| HmimArOMe,NO2 | 1.698(2) | 105.1(2) | 3.292(2) | 2.39(3) | 173(3) | 45.72 | 68.07 |
angle between planes defined by S1–C1–N1 ⋯ S2 and S2–C2–N2 ⋯ S1.
angle between planes defined by the 5-membered heterocycle and 6-membered aryl rings.
Conclusions
In summary, the structures of imidazole-2-thiones that feature electronically diverse 1-aryl substituents, namely HmimAr [Ar = 3,4,5-C6H2(OMe)3, 2,4-C6H3(NO2)(OMe), 2,4,6-C6H2Cl3 and 3,5-C6H3(CF3)2], have been determined by X-ray diffraction and shown to exist as “head-to-head” hydrogen-bonded dimers in the solid state, with [ (8)] motifs. The N,N′-aryldiethoxyethylthiourea precursors (H2detuAr) have also been analyzed by X-ray diffraction, thereby demonstrating that the structures are strongly influenced by the nature of the aryl substituents, especially with respect to intermolecular hydrogen bonding interactions. For example, H2detuAr(CF3)2 is a dimer that features 8-membered rings, H2detuArOMe,NO2 consists of chains of 6-membered rings, H2detuArCl3 consists of chains of 9-membered rings, and H2detuAr(OMe)3 consists of chains of 16-membered rings. In addition to these different hydrogen bonding networks, the substituents also influence the trans-trans (syn) and trans-cis (anti) preferences. Thus, H2detuArCl3 and H2detuAr(OMe)3 adopt a trans-cis (anti) disposition of N–H groups, whereas H2detuAr(CF3)2 and H2detuArOMe,NO2 adopt a trans-trans (syn) disposition. N,N′-aryldiethoxyethylthioureas have not been previously structurally characterized and the variety of hydrogen bonding networks observed here have ramifications with respect to the use of such compounds in crystal engineering.
Experimental Section
General Considerations
NMR spectra were measured on Bruker 400 DRX and Bruker Avance 500 DMX spectrometers. 1H NMR spectra are reported in ppm relative to SiMe4 (δ = 0) and were referenced internally with respect to the protio solvent impurity (δ 7.16 for C6D5H and 2.50 for Me2SO-d5).52 13C NMR spectra are reported in ppm relative to SiMe4 (δ = 0) and were referenced internally with respect to the solvent (δ 39.52 for Me2SO-d5).52 19F NMR spectra are reported in ppm relative to CFCl3 (δ = 0) and were obtained by using the Ξ/100% value of 94.094011.53 Coupling constants are given in hertz. All chemicals were purchased from Sigma-Aldrich.
X‐ray structure determinations
Single crystal X-ray diffraction data were collected on a Bruker Apex II diffractometer and crystal data, data collection and refinement parameters are summarized in Table 4. All data were corrected for absorption (SADABS) and the structures were solved using direct methods and standard difference map techniques, and were refined by full‐matrix least‐squares procedures on F2 with SHELXTL (Version 6.12).54 Hydrogen atoms attached to carbon were refined in calculated positions (AFIX 43 for sp CH groups, AFIX 23 for sp2 CH2 groups, AFIX 13 for sp3 CH groups, and AFIX 137 for methyl groups) with a displacement parameter of Uiso(H) = 1.2Uiso(C) for CH and CH2 groups and Uiso(H) = 1.5Uiso(C) for CH3 groups. The positional parameters of hydrogen atoms attached to nitrogen were refined freely, while the displacement parameters were either freely refined or assigned values of Uiso(H) = 1.2Uiso(N). The CF3 groups of H2detuAr(CF3)2 and HmimAr(CF3)2 were disordered and were modeled by using SADI, SIMU, ISOR and RIGU commands for the disordered components. Molecular structures were viewed using SHELXTL54 and Mercury.55
Table 4.
Crystal, intensity collection and refinement data.
| H2detuArCl3 | H2detuAr(OMe)3 | H2detuAr(CF3)2 | H2detuArOMe,NO2 | |
|---|---|---|---|---|
| crystal system | Monoclinic | Triclinic | Monoclinic | Monoclinic |
| formula | C13H17Cl3N2O2S | C16H26N2O5S | C15H18F6N2O2S | C14H21N3O5S |
| formula weight | 371.70 | 358.45 | 404.37 | 343.40 |
| space group | P21/c | P1̄ | P21/n | P21/c |
| a/Å | 6.769(2) | 10.344(3) | 12.5507(13) | 13.241(4) |
| b/Å | 23.886(8) | 12.952(4) | 13.4265(14) | 15.160(4) |
| c/Å | 10.834(4) | 13.814(4) | 21.715(2) | 8.398(2) |
| α/° | 90 | 95.357(4) | 90 | 90 |
| β/° | 90.947(5) | 95.836(4) | 98.920(2) | 101.009(4) |
| γ/° | 90 | 92.996 (4) | 90 | 90 |
| V/Å3 | 1751.4(10) | 1829.5(9) | 3615.0(6) | 1654.7(8) |
| Z | 4 | 4 | 8 | 4 |
| temperature (K) | 150(2) | 150(2) | 150(2) | 150(2) |
| radiation (λ, Å) | 0.71073 | 0.71073 | 0.71073 | 0.71073 |
| ρ (calcd.) g cm-3 | 1.410 | 1.301 | 1.486 | 1.378 |
| μ (Mo Kα), mm-1 | 0.646 | 0.204 | 0.250 | 0.224 |
| θ max, deg. | 30.67 | 30.36 | 30.03 | 28.28 |
| no. of data collected | 27726 | 28972 | 55289 | 8040 |
| no. of data | 5411 | 10893 | 10539 | 4104 |
| no. of parameters | 200 | 458 | 713 | 219 |
| R1 [I > 2ω(I)] | 0.0505 | 0.0498 | 0.0509 | 0.0558 |
| wR2 [I > 2ω(I)] | 0.0986 | 0.1144 | 0.1153 | 0.0641 |
| R1 [all data] | 0.0991 | 0.1013 | 0.0844 | 0.1648 |
| wR2 [all data] | 0.1151 | 0.1356 | 0.1331 | 0.0834 |
| Rint | 0.0703 | 0.0547 | 0.0412 | 0.1117 |
| GOF | 1.015 | 1.027 | 1.019 | 1.003 |
| HmimArCl3 | HmimAr(OMe)3 | HmimAr(CF3)2 | HmimArOMe,NO2 | |
|---|---|---|---|---|
| crystal system | Monoclinic | Monoclinic | Orthorhombic | Monoclinic |
| formula | C9H5Cl3N2S | C12H14N2O3S | C11H6F6N2S | C10H9N3O3S |
| formula weight | 279.56 | 266.31 | 312.24 | 251.26 |
| space group | P21/c | P21/c | P212121 | C2/c |
| a/Å | 7.4408(8) | 7.2383(6) | 8.4302(5) | 13.747(5) |
| b/Å | 20.454(2) | 7.9459(7) | 23.8152(15) | 12.625(4) |
| c/Å | 7.1759(8) | 22.324(2) | 36.666(2) | 13.632(5) |
| α/° | 90 | 90 | 90 | 90 |
| β/° | 91.0376(14) | 93.0750(10) | 90 | 106.496(5) |
| γ/° | 90 | 90 | 90 | 90 |
| V/Å3 | 1091.9(2) | 1282.12(19) | 7361.4(8) | 2268.7(14) |
| Z | 4 | 4 | 24 | 8 |
| temperature (K) | 130(2) | 150(2) | 130(2) | 130(2) |
| radiation (λ, Å) | 0.71073 | 0.71073 | 0.71073 | 0.71073 |
| ρ (calcd.) g cm-3 | 1.701 | 1.380 | 1.690 | 1.471 |
| μ (Mo Kα), mm-1 | 0.993 | 0.254 | 0.329 | 0.285 |
| θ max, deg. | 30.51 | 30.61 | 32.63 | 26.37 |
| no. of data collected | 17407 | 7575 | 117976 | 12681 |
| no. of data | 3337 | 3945 | 22429 | 2330 |
| no. of parameters | 139 | 170 | 1247 | 158 |
| R1 [I > 2ω(I)] | 0.0276 | 0.0426 | 0.0381 | 0.0449 |
| wR2 [I > 2ω(I)] | 0.0722 | 0.0914 | 0.0882 | 0.1128 |
| R1 [all data] | 0.0283 | 0.0745 | 0.0358 | 0.0550 |
| wR2 [all data] | 0.0728 | 0.1042 | 0.0872 | 0.1182 |
| Rint | 0.0327 | 0.0417 | 0.0256 | 0.0670 |
| GOF | 1.128 | 1.049 | 1.082 | 1.120 |
| Flack parameter | – | – | 0.34(4) | – |
Syntheses
H2detuArCl3
Aminoacetaldehyde diethyl acetal (6.5 g, 49 mmol) was added via syringe over a period of 1 minute to a rapidly stirred solution of 2,4,6-trichlorophenyl isothiocyanate (13.1 g, 55 mmol) in EtOH (250 mL). The mixture was refluxed for 3 hours under an inert atmosphere. After this period, the solvent was removed in vacuo and the residue obtained was dissolved in CH2Cl2 (100 mL). Pentane (100 mL) was added to the solution, thereby resulting in the formation of a suspension that was placed overnight at −15°C. The mixture was filtered and the precipitate was dried in vacuo to give H2detuArCl3 as a white solid (17.7 g, 98%). Colorless crystals of H2detuArCl3 suitable for X-ray diffraction were obtained via slow diffusion of hexanes into a solution in CH2Cl2. Anal. calcd. for H2detuArCl3: C, 42.0; H, 4.6; N, 7.5. Found: C, 42.0; H, 4.3; N, 7.5. 1H NMR (Me2SO-d6): δ 1.14 [br s, 6H of C(H)(OCH2CH3)2], 3.53 [br s, 4H of C(H)(OCH2CH3)2], 3.64 [br s, 2H of NCH2C(H)(OCH2CH3)2], 4.70 [br s, 1H of C(H)(OCH2CH3)2], 7.71 [br s, 2H of C6H2Cl3], 7.87 [br s, 1H of NH], 9.27 [br s, 1H of NH]. 13C{1H} NMR (Me2SO-d6): δ 15.3 [CH3 of C(H)(OCH2CH3)2], 46.9 [CH2 of NCH2C(H)(OCH2CH3)2], 62.0 [CH2 of C(H)O(CH2CH3)2], 99.7 [CH of C(H)(OCH2CH3)2], 128.2 [CH of C6H2Cl3], 128.4 [CH of C6H2Cl3], 132.4 [C of C6H2Cl3], 136.0 [C of C6H2Cl3], not observed [C=S].
HmimArCl3
A rapidly stirred solution of H2detuArCl3 (16.7 g, 45 mmol) in a mixture of EtOH:H2O (250 mL, 9:1) was treated with HClaq (3.4 mL of 12.1 M, 41 mmol) and the mixture was refluxed for 3 hours under an inert atmosphere, resulting in the slow formation of a white precipitate. After this period, the mixture was filtered and the precipitate was dried in vacuo to give HmimArCl3 as a white solid (13.4 g, 94%). Colorless crystals of HmimArCl3 suitable for X-ray diffraction were obtained via slow evaporation of a solution in Me2SO on a watch glass. Anal. calcd. for HmimArCl3: C, 38.7; H, 1.8; N, 10.0. Found: C, 38.3; H, 1.7; N, 9.8. 1H NMR (Me2SO-d6): δ 7.11 [t, 3JH-H = 2, 1H of C3H3N2S], 7.15 [t, 3JH-H = 2, 1H of C3H3N2S], 7.91 [s, 2H of C6H2Cl3], 12.5 [s, 1H of NH]. 13C{1H} NMR (Me2SO-d6): δ 116.3 [CH of C3H3N2S], 118.7 [CH of C3H3N2S], 128.7 [CH of C6H2Cl3], 132.7 [C of C6H2Cl3], 134.9 [C of C6H2Cl3], 135.1 [C of C6H2Cl3], 162.9 [C=S].
H2detuAr(OMe)3
Aminoacetaldehyde diethyl acetal (1.8 g, 14 mmol) was added via syringe over a period of 1 minute to a rapidly stirred solution of 3,4,5-trimethoxyphenyl isothiocyanate (3.3 g, 15 mmol) in EtOH (200 mL). The mixture was refluxed for 2 hours under an inert atmosphere. After this period, the solvent was removed in vacuo and the residue obtained was dissolved in dichloromethane (100 mL). Pentane (100 mL) was added to the solution, thereby resulting in the formation of a suspension. The mixture was filtered and the precipitate was dried in vacuo to give H2detuAr(OMe)3 as a white solid (4.5 g, 93%). Colorless crystals of H2detuAr(OMe)3 suitable for X-ray diffraction were obtained via slow diffusion of hexanes into a solution in CH2Cl2. Anal. calcd. for H2detuAr(OMe)3: C, 53.6; H, 7.3; N, 7.8. Found: C, 53.4; H, 7.1; N, 7.7. 1H NMR (Me2SO-d6): δ 1.13 [t, 3JH-H = 7, 6H of C(H)(OCH2CH3)2], 3.50 [m, 2H of NCH2C(H)(OCH2CH3)2], 3.59 [m, 4H of C(H)(OCH2CH3)2], 3.64 [s, 3H of para-C6H2(OCH3)3], 3.75 [s, 6H of meta-C6H2(OCH3)3], 4.71 [t, 3JH-H = 5, 1H of C(H)(OCH2CH3)2], 6.75 [s, 2H of C6H2(OCH3)3], 7.49 [s, 1H of NH], 9.60 [s, 1H of NH]. 13C{1H} NMR (Me2SO-d6): δ 15.3 [CH3 of C(H)(OCH2CH3)2], 46.3 [CH2 of NCH2C(H)(OCH2CH3)2], 55.8 [CH3 of C6H3(OCH3)3], 60.0 [CH3 of C6H3(OCH3)3], 61.6 [CH2 of C(H)(OCH2CH3)2], 99.7 [CH of C(H)(OCH2CH3)2], 101.1 [CH of C6H2(OCH3)3], 134.5 [C of C6H3(OCH3)3], 134.6 [C of C6H2(OCH3)3], 152.7 [C of C6H2(OCH3)3], 180.3 [C=S].
HmimAr(OMe)3
A rapidly stirred solution of H2detuAr(OMe)3 (4.8 g, 13 mmol) in a mixture of EtOH:H2O (200 mL, 9:1) was treated with HClaq (1.4 mL of 12.1 M, 17 mmol) and the mixture was refluxed for 3 hours under an inert atmosphere. After this period, the volatile components were removed in vacuo from the resulting yellow solution. The residue obtained was dissolved in EtOH (ca. 50 mL) and placed overnight at −15°C, thereby depositing a white precipitate. The mixture was filtered and the precipitate was dried in vacuo to give HmimAr(OMe)3 as a white solid (2.3 g, 65%). Colorless crystals of HmimAr(OMe)3 suitable for X-ray diffraction were obtained via slow diffusion of hexanes into a solution in CH2Cl2. Anal. calcd. for HmimAr(OMe)3: C, 54.1; H, 5.3; N, 10.5. Found: C, 53.9; H, 5.3; N, 10.2. 1H NMR (Me2SO-d6): δ 3.70 [s, 3H of para-C6H2(OCH3)3], 3.80 [s, 6H of meta-C6H2(OCH3)3], 7.00 [s, 2H of C6H2(OCH3)3], 7.05 [d, 3JH-H = 2, 1H of C3H3N2S], 7.29 [d, 3JH-H = 2, 1H of C3H3N2S], 12.36 [br s, 1H of NH]. 13C{1H} NMR (Me2SO-d6): δ 56.1 [CH3 of C6H2(OCH3)3], 60.1 [CH3 of C6H2(OCH3)3], 103.7 [CH of C6H2(OCH3)3], 115.2 [CH of C3H3N2S], 119.7 [CH of C3H3N2S], 133.5 [C of C6H2(OCH3)3], 136.6 [C of C6H2(OCH3)3], 152.6 [C of C6H2(OCH3)3], 161.5 [C=S].
H2detuAr(CF3)2
Aminoacetaldehyde diethyl acetal (4.6 g, 35 mmol) was added via syringe over a period of 1 minute to a rapidly stirred solution of 3,5-bis(trifluoromethyl)phenyl isothiocyanate (8.8 g, 32 mmol) in EtOH (250 mL). The mixture was refluxed for 2 hours under an inert atmosphere. After this period, the solvent was removed in vacuo and the residue obtained was dissolved in Me2CO (100 mL) to give a pale yellow solution. Pentane (ca. 100 mL) was added to the solution until the onset of precipitation was observed. At this point, the mixture was placed at -15°C for 2 days, after which the resulting suspension was filtered to give H2detuAr(CF3)2 as colorless crystals, suitable for X-ray diffraction, that were dried in vacuo (9.7 g, 74%). Anal. calcd. for H2detuAr(CF3)2: C, 44.6; H, 4.5; N, 6.9. Found: C, 44.8; H, 4.4; N, 7.0. 1H NMR (Me2SO-d6): δ 1.15 [t, 3JH-H = 7, 6H of C(H)(OCH2CH3)2], 3.53 [m, 2H of NCH2C(H)(OCH2CH3)2], 3.64 [m, 4H of C(H)(OCH2CH3)2], 4.71 [t, 3JH-H = 5, 1H of C(H)(OCH2CH3)2], 7.71 [s, 1H of para-C6H3(CF3)2], 8.10 [br s, 1H of NH], 8.27 [s, 2H of ortho-C6H3(CF3)2], 10.21 [br s, 1H of NH]. 13C{1H} NMR (Me2SO-d6): δ 15.2 [CH3 of C(H)(OCH2CH3)2], 46.4 [CH2 of NCH2C(H)(OCH2CH3)2], 61.7 [CH2 of C(H)(OCH2CH3)2], 99.4 [CH of C(H)(OCH2CH3)2], 116.1 [CH of C6H3(CF3)2], 121.8 [CH of C6H3(CF3)2], 123.2 [q, 1JC-F = 273, C6H3(CF3)2], 130.2 [q, 2JC-F = 33, C-CF3 of C6H3(CF3)2], 141.8 [C of C6H3(CF3)2], 180.8 [C=S]. 19F{1H} NMR (Me2SO-d6): δ -61.8.
HmimAr(CF3)2
A rapidly stirred solution of H2detuAr(CF3)2 (5.6 g, 14 mmol) in a mixture of EtOH:H2O (200 mL, 9:1) was treated with HClaq (1.4 mL of 12.1 M, 17 mmol) and the mixture was refluxed for 2 hours under an inert atmosphere. After this period, the solvent was removed in vacuo and the residue obtained was dissolved in EtOAc (100 mL). Pentane (100 mL) was added to the solution, which was placed overnight at −15°C, thereby depositing colorless crystals of HmimAr(CF3)2, which were suitable for X-ray diffraction (3.0 g, 69%). Anal. calcd. for HmimAr(CF3)2: C, 42.3; H, 1.9; N, 9.0. Found: C, 42.3; H, 1.8; N, 8.9. 1H NMR (Me2SO-d6): δ 7.16 [t, 3JH-H = 2, 1H of C3H3N2S], 7.58 [t, 3JH-H = 2, 1H of C3H3N2S], 8.15 [s, 1H of para-C6H3(CF3)2], 8.52 [s, 2H of ortho-C6H3(CF3)2], 12.62 [br s, 1H of NH]. 13C{1H} NMR (Me2SO-d6): δ 116.0 [CH of C3H3N2S], 119.2 [CH of C3H3N2S], 121.1 [septet, 3JC-F = 4, para-CH of C6H3(CF3)2], 122.9 [q, 1JC-F = 273, C6H3(CF3)2], 126.5 [q, 3JC-F = 4, ortho-CH of C6H3(CF3)2], 130.5 [q, 2JC-F = 33, C-CF3 of C6H3(CF3)2], 139.1 [C-N of C6H3(CF3)2], 162.2 [C=S]. 19F{1H} NMR (Me2SO-d6): δ -61.4.
H2detuArOMe,NO2
Aminoacetaldehyde diethyl acetal (15.8 g, 118 mmol) was added via syringe over 1 minute to a rapidly stirred solution of 4-methoxy-2-nitrophenyl isothiocyanate (24.7 g, 118 mmol) in EtOH (300 mL). The mixture was refluxed for 90 minutes under an inert atmosphere. After this period, the solvent was removed in vacuo and the residue obtained was dissolved in CH2Cl2 (100 mL). Pentane (ca. 100 mL) was added to the solution until the onset of precipitation was observed. At this point, the mixture was placed at -15°C overnight, after which the resulting bright yellow suspension was filtered and dried in vacuo to give H2detuArOMe,NO2 as flocculent, yellow crystals (28.4 g, 70%). Yellow crystals suitable for X-ray diffraction were obtained via slow diffusion of hexanes into a solution in CH2Cl2. Anal. calcd. for H2detuArOMe,NO2: C, 49.0; H, 6.2; N, 12.2. Found: C, 49.1; H, 6.1; N, 12.3. 1H NMR (Me2SO-d6): δ 1.15 [t, 3JH-H = 7, 6H of C(H)(OCH2CH3)2], 3.54 [m, 4H of C(H)(OCH2CH3)2], 3.64 [m, 2H of NCH2C(H)(OCH2CH3)2], 3.85 [s, 3H of C6H3(NO2)(OCH3)], 4.66 [t, 3JH-H = 5, 1H of C(H)(OCH2CH3)2], 7.27 [dd, 3JH-H = 9, 4JH-H = 3, 1H of C6H3(NO2)(OCH3)], 7.49 [d, 4JH-H = 3, 1H of C6H3(NO2)(OCH3)], 7.57 [d, 3JH-H = 9, 1H of C6H3(NO2)(OCH3)], 8.13 [m, 1H of NH], 9.51 [s, 1H of NH]. 13C{1H} NMR (Me2SO-d6): δ 15.3 [CH3 of C(H)(OCH2CH3)2], 46.8 [CH2 of NCH2C(H)(OCH2CH3)2], 56.0 [CH3 of C6H3(NO2)(OCH3)], 61.9 [CH2 of C(H)(OCH2CH3)2], 99.7 [CH of C(H)(OCH2CH3)2], 108.6 [CH of C6H3(NO2)(OCH3)], 119.7 [CH of C6H3(NO2)(OCH3)], 126.1 [C of C6H3(NO2)(OCH3)], 131.6 [CH of C6H3(NO2)(OCH3)], 145.1 [C of C6H3(NO2)(OCH3)], 156.8 [C of C6H3(NO2)(OCH3)], 182.5 [C=S].
HmimArOMe,NO2
A rapidly stirred solution of H2detuArOMe,NO2 (27.1 g, 79 mmol) in a mixture of EtOH:H2O (300 mL, 9:1) was treated with HClaq (6.0 mL of 12.1 M, 73 mmol). The mixture was refluxed for 3 hours under an inert atmosphere, resulting in the formation of a light orange precipitate. The mixture was allowed to cool to room temperature and filtered. The precipitate was washed with EtOH (ca. 50 mL) and dried in vacuo to give HmimArOMe,NO2 as a yellow-orange solid (18.4 g, 93%). Orange crystals suitable for X-ray diffraction were obtained via slow evaporation of a solution in Me2SO on a watch glass. Anal. calcd. for HmimArOMe,NO2: C, 47.8; H, 3.6; N, 16.7. Found: C, 47.4; H, 3.3; N, 16.3. 1H NMR (Me2SO-d6): δ 3.92 [s, 3H of C6H3(NO2)(OCH3)], 7.08 [t, 3JH-H = 2, 1H of C3H3N2S], 7.24 [t, 3JH-H = 2, 1H of C3H3N2S], 7.43 [dd, 3JH-H = 9, 4JH-H = 3, 1H of C6H3(NO2)(OCH3)], 7.51 [d, 3JH-H = 9, 1H of C6H3(NO2)(OCH3)], 7.67 [d, 4JH-H = 3, 1H of C6H3(NO2)(OCH3)], 12.37 [s, 1H of NH]. 13C{1H} NMR (Me2SO-d6): δ 56.4 [C6H3(NO2)(OCH3)], 110.3 [CH of C6H3(NO2)(OCH3)], 115.6 [CH of C3H3N2S], 119.8 [CH of C3H3N2S], 119.9 [CH of C6H3(NO2)(OCH3)], 123.6 [C of C6H3(NO2)(OCH3)], 131.5 [CH of C6H3(NO2)(OCH3)], 146.4 [C of C6H3(NO2)(OCH3)], 159.4 [C of C6H3(NO2)(OCH3)], 162.9 [C=S].
Supplementary Material
Figure 9.

Hydrogen bonding network for H2detuArCl3.
Figure 12.

Molecular structure of hydrogen bonded HmimAr(OMe)3.
Figure 13.

Molecular structure of hydrogen bonded HmimAr(CF3)2. Only two of the six crystallographically independent molecules are shown.
Acknowledgments
Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM046502. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Footnotes
Electronic Supplementary Information (ESI). X-ray data in the form of CIF files for all compounds, CCDC #991539-991546; fully labeled figures of all compounds, crystal packing diagrams, and tables of intermolecular interactions.
References
- 1.(a) Abramov ND, Trzhtsinskaya BV. Chem Heterocycl Compd. 1988;24:1309–1321. [Google Scholar]; (b) Trzhtsinskaya BV, Abramova ND. Sulfur Rep. 1991;10:389–430. [Google Scholar]
- 2.(a) Kister J, Assef G, Mille G, Metzger J. Can J Chem. 1979;57:813–821. [Google Scholar]; (b) Van Lommen G, Doyon J, Coesemans E, Boeckx S, Cools M, Buntinx M, Hermans B, VanWauwe J. Bioorg Med Chem Lett. 2005;15:497–500. doi: 10.1016/j.bmcl.2004.11.064. [DOI] [PubMed] [Google Scholar]; (c) Kruse LI, Kaiser C, DeWolf WE, Jr, Frazee JS, Ross ST, Wawro J, Wise M, Flaim KE, Sawyer JL, Erickson RW, Ezekiel M, Ohlstein EH, Berkowitz BA. J Med Chem. 1987;30:486–494. doi: 10.1021/jm00386a008. [DOI] [PubMed] [Google Scholar]; (d) Wolfe DM, Schreiner PR. Synthesis. 2007:2002–2008. [Google Scholar]; (e) Laufer S, Wagner G, Kotschenreuther D. Angew Chem Int Edit. 2002;41:2290–2293. doi: 10.1002/1521-3773(20020703)41:13<2290::AID-ANIE2290>3.0.CO;2-R. [DOI] [PubMed] [Google Scholar]; (f) Phillips BT, Claremon DA, Varga SL. Synthesis. 1990:761–763. [Google Scholar]; (g) Feroci M, Orsini M, Inesi A. Adv Synth Catal. 2009;351:2067–2070. [Google Scholar]; (h) Rong Y, Al-Harbi A, Kriegel B, Parkin G. Inorg Chem. 2014;52:7172–7182. doi: 10.1021/ic400788g. [DOI] [PubMed] [Google Scholar]; (i) Jones RG, Kornfeld EC, McLaughlin KC, Anderson RC. J Am Chem Soc. 1949;71:4000–4002. [Google Scholar]; (j) Bedford CD, Harris RN, III, Howd RA, Goff DA, Koolpe GA, Petesch M, Koplovitz I, Sultan WE, Musallam HA. J Med Chem. 1989;32:504–516. doi: 10.1021/jm00122a035. [DOI] [PubMed] [Google Scholar]; (k) Bailey PJ, Dawson A, McCormack C, Moggach SA, Oswald IDH, Parsons S, Rankin DWH, Turner A. Inorg Chem. 2005;44:8884–8898. doi: 10.1021/ic0505293. [DOI] [PubMed] [Google Scholar]; (l) Markwalder JA, Pottorf RS, Seitz SP. Synlett. 1997:521–522. [Google Scholar]; (m) O-Yang C, Rotstein DM, Labadie SS, Walker KAM. Synlett. 1995:655–658. [Google Scholar]; (n) Loksha YM, Pedersen EB, El-Barbary AA, El-Badawi MA, Nielsen C. J Heterocyclic Chem. 2003;40:593–599. [Google Scholar]; (o) Xu J, Yadan JC. Synlett. 1995:239–241. [Google Scholar]; (p) Cassidy CS, Reinhardt LA, Cleland WW, Frey PA. J Chem Soc, Perkin Trans. 1999;2:635–641. [Google Scholar]
- 3.(a) Johnson AL, Kauer JC, Sharma DC, Dorfman RI. J Med Chem. 1969;12:1024–1028. doi: 10.1021/jm00306a013. [DOI] [PubMed] [Google Scholar]; (b) Hirashima A, Morimoto M, Ohta H, Kuwano E, Taniguchi E, Eto M. Int J Mol Sci. 2002;3:56–68. [Google Scholar]; (c) Matsuda K, Yanagisawa I, Isomura Y, Mase T, Shibanuma T. Synth Commun. 1997;27:3565–3571. [Google Scholar]; (d) Kruse LI, Kaiser C, DeWolf WE, Jr, Frazee JS, Garvey E, Hilbert EL, Faulkner WA, Flaim KE, Sawyer JL, Berkowitz BA. J Med Chem. 1986;29:2465–2472. doi: 10.1021/jm00162a008. [DOI] [PubMed] [Google Scholar]
- 4.(a) Flakus HT, Miros A, Jones PG. Spectrochim Acta Part A. 2002;58:225–237. doi: 10.1016/s1386-1425(01)00531-5. [DOI] [PubMed] [Google Scholar]; (b) Vampa G, Benvenuti S, Severi F, Malmusi L, Antolini L. J Heterocyclic Chem. 1995;32:227–234. [Google Scholar]; (c) Raper ES, Creighton JR, Oughtred RE, Nowell IW. Acta Crystallogr. 1983;B39:355–360. [Google Scholar]; (d) Balestrero RS, Forkey DM, Russell JG. Magn Reson Chem. 1986;24:651–655. [Google Scholar]; (e) Garner M, Armstrong DR, Reglinski J, Smith WE, Wilson R, McKillop JH. Bioorg Med Chem Lett. 1994;4:1357–1360. [Google Scholar]; (f) Raper ES. Coord Chem Rev. 1985;61:115–184. [Google Scholar]; (g) Form GR, Raper ES, Downie TC. Acta Crystallogr. 1976;B32:345–348. [Google Scholar]; (h) Simanek EE, Tsoi A, Wang CCC, Whitesides GM, McBride MT, Palmore GTR. Chem Mat. 1997;9:1954–1961. [Google Scholar]; (i) McBride MT, Luo TJM, Palmore GTR. Cryst Growth Des. 2001;1:39–46. [Google Scholar]
- 5.Stadelman BS, Brumaghim JL. ACS Symp Ser. 2013;1152:33–70. [Google Scholar]
- 6.For example, methimazole is sold by Aldrich under the name 2-mercapto-1-methylimidazole.
- 7.(a) Cooper DS. New Engl J Med. 2005;352:905–917. doi: 10.1056/NEJMra042972. [DOI] [PubMed] [Google Scholar]; (b) Fumarola A, Di Fiore A, Dainelli M, Grani G, Calvanese A. Exp Clin Endocrinol Diabet. 2010;118:678–684. doi: 10.1055/s-0030-1253420. [DOI] [PubMed] [Google Scholar]
- 8.Manna D, Roy G, Mugesh G. Acc Chem Res. 2013;46:2706–2715. doi: 10.1021/ar4001229. [DOI] [PubMed] [Google Scholar]
- 9.(a) Kruse LI, Kaiser C, DeWolf WE, Jr, Frazee JS, Garvey E, Hilbert EL, Faulkner WA, Flaim KE, Sawyer JL, Berkowitz BA. J Med Chem. 1986;29:2465–2472. doi: 10.1021/jm00162a008. [DOI] [PubMed] [Google Scholar]; (b) Ross ST, Kruse LI, Ohlstein EH, Erickson RW, Ezekiel M, Flaim KE, Sawyer JL, Berkowitz BA. J Med Chem. 1987;30:1309–1313. doi: 10.1021/jm00391a008. [DOI] [PubMed] [Google Scholar]; (c) Kruse LI, Kaiser C, DeWolf WE, Finkelstein JA, Frazee JS, Hilbert EL, Ross ST, Flaim KE, Sawyer JL. J Med Chem. 1990;33:781–789. doi: 10.1021/jm00164a051. [DOI] [PubMed] [Google Scholar]; (d) Kruse LI, DeWolf WE, Jr, Chambers PA, Goodhart PJ. Biochemistry. 1986;25:7271–7278. doi: 10.1021/bi00371a004. [DOI] [PubMed] [Google Scholar]; (e) Beliaev A, Learmonth DA, Soares-da-Silva P. J Med Chem. 2006;49:1191–1197. doi: 10.1021/jm051051f. [DOI] [PubMed] [Google Scholar]
- 10.Doyon J, Coesemans E, Boeckx S, Buntinx M, Hermans B, Van Wauwe JP, Gilissen R, De Groot AHJ, Corens D, Van Lommen G. ChemMedChem. 2008;3:660–669. doi: 10.1002/cmdc.200700276. [DOI] [PubMed] [Google Scholar]
- 11.Garcia R, Xavier C, Paulo A, Santos I, Kniess T, Bergmann R, Wüst F. J Labelled Compd Radiopharm. 2005;48:301–315. [Google Scholar]
- 12.See, for example: White JL, Tanski JM, Churchill DG, Rheingold AL, Rabinovich D. J Chem Crystallogr. 2003;33:437–445.Pang K, Figueroa JS, Tonks IA, Sattler W, Parkin G. Inorg Chim Acta. 2009;362:4609–4615. doi: 10.1016/j.ica.2009.05.025.Cingolani A, Effendy, Marchetti F, Pettinari C, Pettinari R, Skelton BW, White AH. Inorg Chem. 2002;41:1151–1161. doi: 10.1021/ic0109391.Fisher MG, Gale PA, Light ME, Quesada R. CrystEngComm. 2008;10:1180–1190.Aggarwal V, Kumar VR, Singh UP. J Chem Crystallogr. 2011;41:121–126.Norris AR, Taylor SE, Buncel E, Bélanger-Gariépy F, Beauchamp AL. Can J Chem. 1983;61:1536–1541.Bell NA, Branston TN, Clegg W, Creighton JR, Cucurull-Sánchez L, Elsegood MRJ, Raper ES. Inorg Chim Acta. 2000;303:220–227.Sultana R, Lobana TS, Sharma R, Castineiras A, Akitsu T, Yahagi K, Aritake Y. Inorg Chim Acta. 2010;363:3432–3441.Dodds CA, Lehmann MA, Ojo JF, Reglinski J, Spicer MD. Inorg Chem. 2004;43:4927–4934. doi: 10.1021/ic0496525.Butler LM, Creighton JR, Oughtred RE, Raper ES, Nowell IW. Inorg Chim Acta. 1983;75:149–154.Oughtred RE, Raper ES, Nowell IW. Inorg Chim Acta. 1984;84:L5–L8.Isaia F, Aragoni MC, Arca M, Caltagirone C, Castellano C, Demartin F, Garau A, Lippolis V, Pintus A. Dalton Trans. 2011;40:4505–4513. doi: 10.1039/c0dt01409e.Isaia F, Aragoni MC, Arca M, Demartin F, Devillanova FA, Floris G, Garau A, Hursthouse MB, Lippolis V, Medda R, Oppo F, Pira M, Verani G. J Med Chem. 2008;51:4050–4053. doi: 10.1021/jm8001857.Atkinson ER, Gardiner DJ, Jackson ARW, Raper ES. Inorg Chim Acta. 1985;98:35–41.Ibrahim MM, Shaban SY. Inorg Chim Acta. 2009;362:1471–1477.Bristow S, Harrison JA, Farrugia LJ. Polyhedron. 1987;6:2177–2180.Docrat A, Morlok MM, Bridgewater BM, Churchill DG, Parkin G. Polyhedron. 2004;23:481–488.Morlok MM, Docrat A, Janak KE, Tanski JM, Parkin G. Dalton Trans. 2004:3448–3452. doi: 10.1039/B412147C.Matsunaga Y, Fujisawa K, Amir N, Miyashita Y, Okamoto KI. J Coord Chem. 2005;58:1047–1061.
- 13.(a) Melnick JG, Parkin G. Science. 2007;317:225–227. doi: 10.1126/science.1144314. [DOI] [PubMed] [Google Scholar]; (b) Melnick JG, Yurkerwich K, Parkin G. Inorg Chem. 2009;48:6763–6772. doi: 10.1021/ic900721g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.(a) Parkin G. New J Chem. 2007;31:1996–2014. doi: 10.1039/b712012e. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Parkin G. Chem Rev. 2004;104:699–767. doi: 10.1021/cr0206263. [DOI] [PubMed] [Google Scholar]; (c) Parkin G. Chem Commun. 2000:1971–1985. [Google Scholar]
- 15.(a) Vahrenkamp H. Acc Chem Res. 1999;32:589–596. [Google Scholar]; (b) Vahrenkamp H. Bioinorganic Chemistry – Transition Metals in Biology and their Coordination Chemistry. Wiley-VCH; Weinheim: 1997. pp. 540–551. [Google Scholar]; (c) Vahrenkamp H. Dalton Trans. 2007:4751–4759. doi: 10.1039/b712138e. [DOI] [PubMed] [Google Scholar]
- 16.(a) Landry VK, Melnick JG, Buccella D, Pang K, Ulichny JC, Parkin G. Inorg Chem. 2006;45:2588–2597. doi: 10.1021/ic051975t. [DOI] [PubMed] [Google Scholar]; (b) Figueroa JS, Melnick JG, Parkin G. Inorg Chem. 2006;45:7056–7058. doi: 10.1021/ic061353n. [DOI] [PubMed] [Google Scholar]; (c) Pang K, Quan SM, Parkin G. Chem Commun. 2006:5015–5017. doi: 10.1039/b611654j. [DOI] [PubMed] [Google Scholar]; (d) Pang K, Tanski JM, Parkin G. Chem Commun. 2008:1008–1010. doi: 10.1039/b714466k. [DOI] [PubMed] [Google Scholar]; (e) Hill AF, Owen GR, White AJP, Williams DJ. Angew Chem, Int Ed. 1999;38:2759–2761. [PubMed] [Google Scholar]; (f) Crossley IR, Hill AF, Willis AC. Organometallics. 2005;24:1062–1064. [Google Scholar]; (g) Crossley IR, Foreman MR, Hill AF, White AJP, Williams DJ. Chem Commun. 2005:221–223. doi: 10.1039/b413305f. [DOI] [PubMed] [Google Scholar]; (h) Crossley IR, Hill AF, Willis AC. Organometallics. 2010;29:326–336. [Google Scholar]
- 17.Cambridge Structural Database (Version 5.34) 3D Search and Research Using the Cambridge Structural Database. Allen FH, Kennard O. Chemical Design Automation News. 1993;8(1):1 & 31–37. [Google Scholar]
- 18.Docrat A, Morlok MM, Bridgewater BM, Churchill DG, Parkin G. Polyhedron. 2004;23:481–488. [Google Scholar]
- 19.Several derivatives that also feature 4-substituents have, nevertheless, been reported. See: Perez-Garrido S, Conde A, Marquez R. Acta Crystallogr Sect B. 1974;B30:2348–2352.Barragan I, Lopez-Castro A, Marquez R. Acta Crystallogr Sect B. 1977;B33:2244–2248.Barragan I, Lopez-Castro A, Marquez R. Acta Crystallogr Sect B. 1978;B34:295–298.
- 20.Koketsu M, Ishihara H. Curr Org Synth. 2006;3:439–455. [Google Scholar]
- 21.Pandeya SN, Ram P, Shankar V. J Sci Ind Res. 1981;40:458–466. [Google Scholar]
- 22.(a) Chikhalia KH, Patel MJ. J Enzym Inhib Med Chem. 2009;24:960–966. doi: 10.1080/14756360802560966. [DOI] [PubMed] [Google Scholar]; (b) Phetsuksiri B, Baulard AR, Cooper AM, Minnikin DE, Douglas JD, Besra GS, Brennan PJ. Antimicrob Agents Chemother. 1999;43:1042–1051. doi: 10.1128/aac.43.5.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Seth PP, Ranken R, Robinson DE, Osgood SA, Risen LA, Rodgers EL, Migawa MT, Jefferson EA, Swayze EE. Bioorg Med Chem Lett. 2004;14:5569–5572. doi: 10.1016/j.bmcl.2004.08.059. [DOI] [PubMed] [Google Scholar]
- 23.Mishra A, Batra S. Curr Top Med Chem. 2013;13:2011–2025. doi: 10.2174/15680266113139990126. [DOI] [PubMed] [Google Scholar]
- 24.Stefanska J, Szulczyk D, Koziol AE, Miroslaw B, Kedzierska E, Fidecka S, Busonera B, Sanna G, Giliberti G, La Colla P, Struga M. Eur J Med Chem. 2012;55:205–213. doi: 10.1016/j.ejmech.2012.07.020. [DOI] [PubMed] [Google Scholar]
- 25.(a) Phuong T, Khac-Minh T, Van Ha NT, Phuong HTN. Bioorg Med Chem Lett. 2004;14:653–656. doi: 10.1016/j.bmcl.2003.11.044. [DOI] [PubMed] [Google Scholar]; (b) Ramadas K, Suresh G, Janarthanan N, Masilamani S. Pestic Sci. 1998;52:145–151. [Google Scholar]; (c) Krause G, Franke R, Vassilev GN. Biochem Physiol Pflanz. 1979;174:128–138. [Google Scholar]; (d) Rodriguez-Fernandez E, Manzano JL, Benito JJ, Hermosa R, Monte E, Criado JJ. J Inorg Biochem. 2005;99:1558–1572. doi: 10.1016/j.jinorgbio.2005.05.004. [DOI] [PubMed] [Google Scholar]
- 26.(a) Galabov AS, Galabov BS, Neykova NA. J Med Chem. 1980;23:1048–1051. doi: 10.1021/jm00183a016. [DOI] [PubMed] [Google Scholar]; (b) Tilley JW, Levitan P, Kramer MJ. J Med Chem. 1979;22:1009–1010. doi: 10.1021/jm00194a025. [DOI] [PubMed] [Google Scholar]; (c) Todoulou OG, Papadakivaliraki AE, Filippatos EC, Ikeda S, Declercq E. Eur J Med Chem. 1994;29:127–131. [Google Scholar]
- 27.Karakus S, Kucukguzel SG, Kucukguzel I, De Clercq E, Pannecouque C, Andrei G, Snoeck R, Sahin F, Bayrak OF. Eur J Med Chem. 2009;44:3591–3595. doi: 10.1016/j.ejmech.2009.02.030. [DOI] [PubMed] [Google Scholar]
- 28.(a) Karakus S, Kucukguzel SG, Kucukguzel I, De Clercq E, Pannecouque C, Andrei G, Snoeck R, Sahin F, Bayrak OF. Eur J Med Chem. 2009;44:3591–3595. doi: 10.1016/j.ejmech.2009.02.030. [DOI] [PubMed] [Google Scholar]; (b) Kucukguzel I, Tatar E, Kucukguzel SG, Rollas S, De Clercq E. Eur J Med Chem. 2008;43:381–392. doi: 10.1016/j.ejmech.2007.04.010. [DOI] [PubMed] [Google Scholar]
- 29.(a) Doub L, Richardson LM, Herbst DR, Black ML, Stevenson OL, Bambas LL, Youmans GP, Youmans AS. J Am Chem Soc. 1958;80:2205–2217. [Google Scholar]; (b) Glasser AC, Doughty RM. J Pharm Sci. 1962;51:1031–1033. doi: 10.1002/jps.2600511103. [DOI] [PubMed] [Google Scholar]
- 30.(a) Zuliani V, Bordi F, Rivara M, Silva C, Vacondio F, Morini G, Rivara S, Barocelli E, Ballabeni V, Bertoni S, Magnanini F, Plazzi PV. Il Farmaco. 2003;58:891–899. doi: 10.1016/s0014-827x(03)00147-2. [DOI] [PubMed] [Google Scholar]; (b) Arrang JM, Garbarg M, Lancelot JC, Lecomte JM, Pollard H, Robba M, Schunack W, Schwartz JC. Nature. 1987;327:117–123. doi: 10.1038/327117a0. [DOI] [PubMed] [Google Scholar]; (c) van der Goot H, Schepers MJP, Sterk GJ, Timmerman H. Eur J Med Chem. 1992;27:511–517. [Google Scholar]
- 31.(a) Lippert KM, Hof K, Gerbig D, Ley D, Hausmann H, Guenther S, Schreiner PR. Eur J Org Chem. 2012:5919–5927. [Google Scholar]; (b) Zhang Z, Schreiner PR. Chem Soc Rev. 2009;38:1187–1198. doi: 10.1039/b801793j. [DOI] [PubMed] [Google Scholar]; (c) Takemoto Y. Chem Pharm Bull. 2010;58:593–601. doi: 10.1248/cpb.58.593. [DOI] [PubMed] [Google Scholar]
- 32.Kotke M, Schreiner PR. In: Hydrogen Bonding in Organic Synthesis. Pihko PM, editor. Wiley; 2009. pp. 141–251. Chapter 6. [Google Scholar]
- 33.(a) Sigman MS, Jacobsen EN. J Am Chem Soc. 1998;120:4901–4902. [Google Scholar]; (b) Sigman MS, Vachal P, Jacobsen EN. Angew Chem Int Ed. 2000;39:1279–1281. doi: 10.1002/(sici)1521-3773(20000403)39:7<1279::aid-anie1279>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]; (c) Okino T, Hoashi Y, Takemoto Y. J Am Chem Soc. 2003;125:12672–12673. doi: 10.1021/ja036972z. [DOI] [PubMed] [Google Scholar]; (d) Wittkopp A, Schreiner PR. Chem Eur J. 2003;9:407–414. doi: 10.1002/chem.200390042. [DOI] [PubMed] [Google Scholar]; (e) Sohtome Y, Tanatani A, Hashimoto Y, Nagasawa K. Tetrahedron Lett. 2004;45:5589–5592. [Google Scholar]; (f) Herrera RP, Sgarzani V, Bernardi L, Ricci A. Angew Chem Int Ed. 2005;44:6576–6579. doi: 10.1002/anie.200500227. [DOI] [PubMed] [Google Scholar]; (g) McCooey SH, Connon SJ. Angew Chem Int Ed. 2005;44:6367–6370. doi: 10.1002/anie.200501721. [DOI] [PubMed] [Google Scholar]; (h) Sohtome Y, Hashimoto Y, Nagasawa K. Adv Synth Catal. 2005;347:1643–1648. [Google Scholar]; (i) Vakulya B, Varga S, Csámpai A, Soós T. Org Lett. 2005;7:1967–1969. doi: 10.1021/ol050431s. [DOI] [PubMed] [Google Scholar]; (j) Wang J, Li H, Yu X, Zu L, Wang W. Org Lett. 2005;7:4293–4296. doi: 10.1021/ol051822+. [DOI] [PubMed] [Google Scholar]; (k) Berkessel A, Roland K, Neudörfl JM. Org Lett. 2006;8:4195–4198. doi: 10.1021/ol061298m. [DOI] [PubMed] [Google Scholar]; (l) Cao CL, Ye MC, Sun XL, Tang Y. Org Lett. 2006;8:2901–2904. doi: 10.1021/ol060481c. [DOI] [PubMed] [Google Scholar]; (m) Miyabe H, Tuchida S, Yamauchi M, Takemoto Y. Synthesis. 2006;19:3295–3300. [Google Scholar]; (n) Liu K, Cui HF, Nie J, Dong KY, Li XJ, Ma JA. Org Lett. 2007;9:923–925. doi: 10.1021/ol0701666. [DOI] [PubMed] [Google Scholar]; (o) Yamaoka Y, Miyabe H, Takemoto Y. J Am Chem Soc. 2007;129:6686–6687. doi: 10.1021/ja071470x. [DOI] [PubMed] [Google Scholar]
- 34.(a) Custelcean R. Chem Commun. 2008:295–307. doi: 10.1039/b708921j. [DOI] [PubMed] [Google Scholar]; (b) Custelcean R, Gorbunova MG, Bonnesen PV. Chem Eur J. 2005;11:1459–1466. doi: 10.1002/chem.200400973. [DOI] [PubMed] [Google Scholar]; (c) Custelcean R, Engle NL, Bonnesen PV. CrystEngComm. 2007;9:452–455. [Google Scholar]
- 35.(a) Taouss C, Thomas L, Jones PG. CrystEngComm. 2013;15:6829–6836. [Google Scholar]; (b) Sun H, Mei H, Xie C, Lu Z, Han J, Pan Y. Inorg Chem Commun. 2010;13:1361–1365. [Google Scholar]; (c) Paisner K, Zakharov LN, Doxsee KM. Cryst Growth Des. 2010;10:3757–3762. [Google Scholar]
- 36.HmimAr(CF3)2 (reference 3b) and HmimArOMe,NO2 (references 3a,b) have been briefly described, but complete synthetic details and NMR spectroscopic data were not provided.
- 37.Gosavi RK, Agarwala U, Rao CNR. J Am Chem Soc. 1967;89:235–239. [Google Scholar]
- 38.Cis-cis rotamers have been observed in the solid state for cyclic thioureas that are forced to have this structure. See: McBride MT, Luo TJM, Palmore GTR. Cryst Growth Des. 2001;1:39–46.
- 39.Lenthall JT, Foster JA, Anderson KM, Probert MR, Howard JAK, Steed JW. CrystEngComm. 2011;13:3202–3212. [Google Scholar]
- 40.Allen FH, Bird CM, Rowland RS, Raithby PR. Acta Crystallogr Sect B. 1997;B53:680–695. [Google Scholar]
- 41.The S ⋯ H distances in the H2detuAr derivatives (2.49 Å – 2.80 Å) are also comparable to the average value in other thiourea and thioamide derivatives (2.45 Å). See: Wood PA, Pidcock E, Allen FH. Acta Crystallogr Sect B. 2008;B64:491–496. doi: 10.1107/S0108768108015437.
- 42.The value of 2.95 Å is obtained from analysis of N–H ⋯ OR2 interactions listed in the Cambridge Structural Database.
- 43.For a discussion of the electronic features of the hydrogen bonding acceptor character of the sulfur in thiourea derivatives, see: Francuski BM, Novakovic SB, Bogdanovic GA. CrystEngComm. 2011;13:3580–3591.
- 44.Cyclic chains are also known. See reference 34.
- 45.Rozas I, Alkorta I, Elguero J. J Phys Chem A. 1998;102:9925–9932. [Google Scholar]
- 46.(a) Etter MC. Acc Chem Res. 1990;23:120–126. [Google Scholar]; (b) Etter MC, MacDonald JC, Bernstein J. Acta Crystallogr Sect B. 1990;B46:256–262. doi: 10.1107/s0108768189012929. [DOI] [PubMed] [Google Scholar]; (c) Bernstein J, Davis RE, Shimoni L, Chang NL. Angew Chem Int Ed. 1995;34:1555–1573. [Google Scholar]
- 47.There are also intramolecular N–H ⋯ O interactions between the N–H and the nitro and ethoxy groups [d(N ⋯ ONO) = 2.68 Å and d(N ⋯ OEt) = 2.78 Å].
- 48.For other examples of this hydrogen bonding network, see: Strukil V, Igrc MD, Fabian L, Eckert-Maksic M, Childs SL, Reid DG, Duer MJ, Halasz I, Mottillo C, Friscic T. Green Chemistry. 2012;14:2462–2473.Qin YQ, Jian FF, Liang TL. Acta Crystallogr Sect E. 2006;E62:o5043–o5044.Sarojini BK, Narayana B, Swamy MT, Yathirajan HS, Bolte M. Acta Crystallogr Sect E. 2007;E63:o3879. doi: 10.1107/S1600536807063362.
- 49.For other examples of thioureas that do not feature hydrogen bonding to sulfur, see reference 48a and: Mizuno H, Kitamura K, Miyao A, Yamagata Y, Wakahara A, Tomita K, Ikehara M. Acta Crystallogr Sect B. 1980;36:902–905.
- 50.Examples of 1-R-imidazole-2-thiones that exhibit a “head-to-head” hydrogen bonded motif include Janin YL, Aubertin AM, Chiaroni A, Riche C, Monneret C, Bisagni E, Grierson DS. Tetrahedron. 1996;52:15157–15170.Hwu JR, Lin SY, Tsay SC, De Clercq E, Leyssen P, Neyts J. J Med Chem. 2011;54:2114–2126. doi: 10.1021/jm101337v.Khan H, Badshah A, Shaheen F, Gieck C, Qureshi RA. Acta Crystallogr Sect E. 2008;E64:o1141. doi: 10.1107/S1600536808015043.Conde A, Moreno E, Marquez R. Acta Crystallogr Sect B. 1975;B31:648–652.Prusiner P, Sundaralingam M. Acta Crystallogr Sect B. 1973;B29:2328–2334.
- 51.Raper ES, Creighton JR, Oughtred RE, Nowell IW. Acta Crystallogr Sect B. 1983;B39:355–360. [Google Scholar]
- 52.Gottlieb HE, Kotlyar V, Nudelman A. J Org Chem. 1997;62:7512–7515. doi: 10.1021/jo971176v. [DOI] [PubMed] [Google Scholar]
- 53.(a) Harris RK, Becker ED, De Menezes SMC, Goodfellow R, Granger P. Pure Appl Chem. 2001;73:1795–1818. [Google Scholar]; (b) Harris RK, Becker ED, De Menezes SMC, Granger P, Hoffman RE, Zilm KW. Pure Appl Chem. 2008;80:59–84. [Google Scholar]
- 54.(a) Sheldrick GM. SHELXTL, An Integrated System for Solving, Refining and Displaying Crystal Structures from Diffraction Data. University of Göttingen; Göttingen, Federal Republic of Germany: 1981. [Google Scholar]; (b) Sheldrick GM. Acta Cryst. 2008;A64:112–122. [Google Scholar]
- 55.Mercury CSD 2.0 - New Features for the Visualization and Investigation of Crystal Structures Macrae CF, Bruno IJ, Chisholm JA, Edgington PR, McCabe P, Pidcock E, Rodriguez-Monge L, Taylor R, van de Streek J, Wood PA. J Appl Cryst. 2008;41:466–470.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
